ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

ClinicalTrials.gov ID: NCT06881784

Public ClinicalTrials.gov record NCT06881784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 5:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 Versus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic RAS[MUT] NSCLC

Study identification

NCT ID
NCT06881784
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Revolution Medicines, Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2025
Primary completion
Nov 30, 2027
Completion
Nov 30, 2030
Last update posted
Mar 11, 2026

2025 – 2030

United States locations

U.S. sites
34
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
Alabama Oncology Birmingham Alabama 35243 Recruiting
MemorialCare Long Beach Medical Center Long Beach California 90806 Recruiting
Yale University, Smillow Cancer Center New Haven Connecticut 06519 Recruiting
Florida Cancer Specialists & Research Institute - South Fort Myers Florida 33901 Recruiting
BRCR Global Plantation Florida 33322 Recruiting
Cancer Care Centers of Breevard Rockledge Florida 32955 Recruiting
Florida Cancer Specialists & Research Institute - North St. Petersburg Florida 33705 Recruiting
Cleveland Clinic Martin North Stuart Florida 34994 Recruiting
Florida Cancer Specialists & Research Institute - East West Palm Beach Florida 33401 Recruiting
University Cancer and Blood Center Athens Georgia 30607 Recruiting
Center for Care and Discovery Chicago Illinois 60637 Recruiting
The University of Kansas Cancer Center Westwood Kansas 66205 Recruiting
Johns Hopkins University of Medicine Baltimore Maryland 21224 Recruiting
Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
Henry Ford Health Detroit Michigan 48202 Recruiting
Washington University School of Medicine - Siteman Cancer Center St Louis Missouri 63110 Recruiting
St. Vincent Frontier Cancer Center Billings Montana 59102 Recruiting
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 Recruiting
Morristown Medical Center (MMCORC) Morristown New Jersey 07960 Recruiting
Roswell Park Cancer Institute Buffalo New York 14263 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
Montefiore Medical Center The Bronx New York 10461 Recruiting
UNC Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill North Carolina 27599 Recruiting
TriHealth Cancer & Blood Institute Research Cincinnati Ohio 45220 Recruiting
Taylor Cancer Research Center Maumee Ohio 43537 Recruiting
Oncology Associates of Oregon PC Eugene Oregon 97401 Recruiting
Avera Cancer Institute Sioux Falls South Dakota 57105 Recruiting
SCRI Oncology Partners - Tennessee Nashville Tennessee 37203 Recruiting
Texas Oncology - South Austin Austin Texas 78745 Recruiting
Texas Oncology Dallas Dallas Texas 75251 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Recruiting
Texas Oncology - Gulf Coast The Woodlands Texas 77380 Recruiting
Utah Cancer Specialists Salt Lake City Utah 84106 Recruiting
Virginia Cancer Specialists Fairfax Virginia 22031 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06881784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 11, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06881784 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →